Medi-Caps Limited announced its unaudited financial results for the quarter and half year ended September 30, 2026. The company reported a net loss of ₹52.68 lakh for the quarter, compared to a loss of ₹58.96 lakh in the previous year. For the half-year ended September 30, 2026, the net loss stood at ₹111.63 lakh. The results were approved by the Board of Directors on November 4, 2026.
Medi-Caps Limited Announces Q2 FY27 Financial Results
Medi-Caps Limited has disclosed its unaudited standalone financial results for the quarter and half year ended September 30, 2026. The company’s Board of Directors approved these results during a meeting held on November 4, 2026.
Standalone Financial Performance
For the quarter ended September 30, 2026, Medi-Caps Limited reported a net loss of ₹52.68 lakh. This compares to a net loss of ₹58.96 lakh for the same period in the previous year. The total income for the quarter was ₹12.87 lakh, with total expenses amounting to ₹65.55 lakh.
The unaudited standalone results for the half-year ended September 30, 2026, showed a net loss of ₹111.63 lakh. This is a significant shift from the profit of ₹28.65 lakh recorded for the corresponding half-year period in the prior year. Total income for the half-year was ₹23.74 lakh, against total expenses of ₹135.37 lakh.
Other Comprehensive Income
In addition to the profit/loss, the company also reported Other Comprehensive Income. For the quarter ended September 30, 2026, this amounted to a loss of ₹6.87 lakh. For the half-year, the Other Comprehensive Income showed a gain of ₹94.74 lakh.
Consolidated Financial Highlights
The consolidated financial results for the half-year ended September 30, 2026, indicate a net loss of ₹232.12 lakh. This includes the results of its wholly-owned subsidiary, Medgel Private Limited. The consolidated total comprehensive income for the period was ₹17.37 lakh.
Key Dates and Filings
The Board meeting commenced at 03:00 P.M. and concluded at 03:55 P.M. on November 4, 2026. The detailed financial results, along with the Statement of Assets and Liabilities and Cash Flow Statement, will be uploaded on the company’s website (www.medicaps.com) and the Stock Exchange website (www.bseindia.com).
A limited review report by the statutory auditors, Rawka & Associates, has been provided, confirming that based on their review, nothing has come to their attention to suggest material misstatements in the accompanying financial statements.
Source: BSE
